Isomark Overview

  • Founded
  • 2005
  • Status
  • Private
  • Employees
  • 11
  • Latest Deal Type
  • Grant
  • Latest Deal Amount
  • $2.22M
Latest Deal Amount
  • Investors
  • 5

Isomark General Information


Developer of non-invasive breath technology designed to detect severe infections. The company's technology monitors personal health and disease states by measuring breath stable isotope carbon-di-oxide markers as early warning of infections like Sepsis and Ventilator Associated Pneumonia, enabling doctors to focus is the pre-symptomatic detection of severe infections.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Diagnostic Equipment
Other Industries
Other Devices and Supplies
Monitoring Equipment
Primary Office
  • 455 Science Drive
  • Suite 155
  • Madison, WI 53711
  • United States
+1 (608) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Isomark Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Grant 01-Jan-2016 $2.22M 00000 Completed Generating Revenue
6. Grant 23-Oct-2014 00.00 00000 Completed Generating Revenue
5. Corporate 01-May-2014 00000 00000 Completed Generating Revenue
4. Angel (individual) 01-Jan-2012 0000 00000 Completed Startup
3. Angel (individual) 23-Jul-2010 00000 00000 Completed Startup
2. Grant Completed Startup
1. Accelerator/Incubator Completed Startup
To view Isomark’s complete valuation and funding history, request access »

Isomark Executive Team (9)

Name Title Board Seat Contact Info
Joe Kremer Chief Executive Officer & Board Member
Daniel Butz Ph.D Co-Founder, Chief Scientific Officer & Board Observer
Hamid Eghbalnia Ph.D Co-Founder & Board Member
Mark Cook Ph.D Co-Founder & Board Member
Fariba Assadi-Porter Ph.D Co-Founder
You’re viewing 5 of 9 executive team members. Get the full list »

Isomark Board Members (6)

Name Representing Role Since
Daniel Sullivan Self Board Member 000 0000
Hamid Eghbalnia Ph.D Isomark Co-Founder & Board Member 000 0000
Joe Kremer Isomark Chief Executive Officer & Board Member 000 0000
Mark Cook Ph.D Isomark Co-Founder & Board Member 000 0000
Tom Still Isomark Board Member 000 0000
You’re viewing 5 of 6 board members. Get the full list »

Isomark Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Isomark Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
U.S. Department of Health and Human Services Government 000 0000 000000 0
National Institutes of Health Government 000 0000 000000 0
Wisconsin Alumni Research Foundation Venture Capital Minority 000 0000 000000 0
Matter Accelerator/Incubator 000 0000 000000 0
Wisconsin Economic Development Corporation Government Minority 000 0000 000000 0
To view Isomark’s complete investors history, request access »